From $267.4 Billion to $404.8 Billion: The Nutraceutical Products Market Journey

The Nutraceutical products market has been growing significantly due to the increasing consumer awareness about health and wellness, along with a rising demand for preventive healthcare. Nutraceuticals are food or part of food that offers medical or health benefits, including the prevention and treatment of …

Cancer Diagnostics Market worth $26.6 billion by 2026

The report “Cancer Diagnostics Market by Product (Consumables (Anitibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology (IVD Testing), Application (Breast Cancer, Lung Cancer), End User (Hospitals) – Global Forecasts to 2026″ The global cancer diagnostics market size is projected to reach USD 26.6 billion by 2026 …

Bioinformatics Market Size to Grow at a CAGR of 13.0% in the Forecast Period of 2022-2027

The global bioinformatics market was valued at USD 10.1 billion in 2022 and is projected to reach USD 18.7 billion by 2027, at a CAGR of 13.0% during the forecast period. The growth of the bioinformatics market is driven by the increasing public and private-sector …

Endoscopic Submucosal Dissection Market worth $483 Million | Revealing Emerging Players with New Data Insights

The global endoscopic submucosal dissection market size is estimated to be USD 347 million in 2022 and is projected to reach 483 million by 2027, at a CAGR of 6.9% during the forecast period. The rising prevalence of GI cancer and disorders across the globe …

Biologics Safety Testing Market worth $6.8 billion | Opportunities, Key Players, Competitive and Regional Analysis

The global biologics safety testing market is projected to reach USD 6.8 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 13.3% during the forecast period. The growth of the global biologics safety testing market is driven by factors such as …

Vitamin D Market Regional Analysis & Global Forecast by 2027

The Vitamin D Market size is estimated to be valued at USD 1.3 billion in 2022 and is projected to reach USD 1.9 billion by 2027, recording a CAGR of 7.1% during the forecast period in terms of value. Increasing consumption of healthy products due to …

COVID-19 Impact on the AI in medical diagnostics Market

AI in medical diagnostics Market

Pandemics such as COVID-19 require investments for additional manpower, equipment, consumables, and other resources to ensure 100% preparedness for safety in hospitals and, if needed, eventual treatment of patients. The COVID-19 pandemic is an accelerator for AI technology by creating opportunities for leveraging these tools …

Embolotherapy Market : Increasing incidences of peripheral vascular diseases

The global embolotherapy market is valued at USD 3.4 billion in 2021 and is expected to reach USD 5.0 billion by 2026, at a CAGR of 8.0% during the forecast period. Increasing incidences of peripheral vascular diseases, liver cancer, strokes, and uterine fibroids coupled with …

Veterinary Software Market: Growing Consolidation of the Veterinary Healthcare Industry

Veterinary Software Market

The veterinary software market to grow from USD 442 million in 2017 to USD 594 million by 2022, at a CAGR of 6.1% during the forecast period.

Benign Prostatic Hyperplasia Treatment Market – Global Forecast to 2026

The benign prostatic hyperplasia treatment market is projected to reach USD 14.1 billion by 2026 from USD 10.8 billion in 2021, at a CAGR of 5.3% from 2021 to 2026. The presence of a large geriatric and target patient population and the improving healthcare infrastructure …

Neuroprosthetics Market – Global Forecast to 2022

Neuroprostheses uses electrodes to interface with the central or peripheral nervous system to restore lost motor or sensory capabilities. These devices can receive neural signals from the external environment & brain, and convert the signals to restore functions such as loss of hearing and vision. …

Mice Model Market – Future Growth and Trends

The global mice model market size is projected to reach USD 1.9 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.4% during the forecast period. Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing implications of mouse clinical trials …